PURE Bioscience (PURE)
(Delayed Data from OTC)
$0.07 USD
0.00 (0.00%)
Updated Apr 25, 2024 10:50 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for PURE Bioscience falls in the month of July .
All items in Millions except EPS data.
7/31/23 | 7/31/22 | 7/31/21 | 7/31/20 | 7/31/19 | |
---|---|---|---|---|---|
Sales | 2 | 2 | 4 | 7 | 2 |
Cost Of Goods | 1 | 1 | 2 | 3 | 1 |
Gross Profit | 1 | 1 | 2 | 4 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 5 | 5 | 4 | 4 | 7 |
Income After Depreciation & Amortization | -4 | -4 | -2 | 0 | -6 |
Non-Operating Income | 0 | 0 | 0 | 0 | -1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -4 | -3 | -2 | 0 | -7 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -3 | -2 | 0 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4 | -3 | -2 | 0 | -7 |
Depreciation Footnote | 7/31/23 | 7/31/22 | 7/31/21 | 7/31/20 | 7/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -4 | -4 | -2 | 0 | -5 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -4 | -4 | -2 | 0 | -6 |
Earnings Per Share Data | 7/31/23 | 7/31/22 | 7/31/21 | 7/31/20 | 7/31/19 |
---|---|---|---|---|---|
Average Shares | 111.40 | 88.84 | 87.17 | 84.61 | 72.88 |
Diluted EPS Before Non-Recurring Items | -0.04 | -0.04 | -0.03 | 0.00 | -0.09 |
Diluted Net EPS (GAAP) | -0.04 | -0.04 | -0.03 | 0.00 | -0.09 |
Fiscal Year end for PURE Bioscience falls in the month of July .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 0.33 | 0.72 | 0.60 | 0.41 | 0.40 |
Cost Of Goods | 0.15 | 0.28 | 0.28 | 0.21 | 0.20 |
Gross Profit | 0.18 | 0.44 | 0.32 | 0.20 | 0.20 |
SG&A, R&D, and Dept/Amort Expenses | 1.15 | 1.15 | 1.03 | 1.07 | 1.26 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.97 | -0.71 | -0.71 | -0.87 | -1.06 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.04 | 0.02 | 0.01 | 0.00 | 0.00 |
Pretax Income | -1.00 | -0.74 | -1.03 | -0.88 | -1.06 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.00 | -0.74 | -1.03 | -0.88 | -1.06 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.00 | -0.74 | -1.03 | -0.88 | -1.06 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 111.86 | 111.86 | 111.42 | 111.36 | 111.36 |
Diluted EPS Before Non-Recurring Items | -0.01 | -0.01 | -0.03 | -0.01 | -0.01 |
Diluted Net EPS (GAAP) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |